We focus on establishing international collaborations with pharmaceutical and biopharmaceutical companies with the goal of bringing innovative therapeutic specialty medicines to the Nordic region that will improve the lives of people in the region.

​

As partnerships and alliances are a key component of our commercial growth strategy, we allocate significant financial and corporate resources to our business development activities and strategies. We recognize and appreciate the value of strong, mutually beneficial business relationships and ensure that our partners receive the resources, attention and focus required to succeed.

Our commercialization team is very knowledgeable, experienced, resourceful and driven by shared goals. We are flexible and can transfer our knowledge to new opportunities in several therapeutic areas.

​

We are constantly looking for opportunities to license or acquire specialty medical products for the Nordic market to meet unmet medical needs. These can be products that have either already been approved by the regional health authorities, have a legal basis available for registration in the region or are in late stages of development (phase III or later).

Our capabilities

• Sales and marketing

• Pricing and tender procedure

• National patient insurance

• Supply chain, including warehousing and distribution

• Market research and analysis

• Supervisory issues

• Pharmacovigilance

• Product registration

Vå